Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER vs Morphine SR for Cancer Pain in Japanese Subjects
NCT01309386Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in cancer pain, sponsored by Janssen Pharmaceutical. Started Aug 2010; status: completed.
02
Drugs
tapentadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01309386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309386.